SGT-001 Micro-dystrophin gene therapy for Duchenne muscular dystrophy
Joel Schneider(Solidus Biosciences (United States)), Carl Morris(Sylvana Research), Diane Golebiowski(University of Massachusetts Chan Medical School), Jorge González(Solidus Biosciences (United States)), Valeria Ricotti(Solidus Biosciences (United States)), Kristy J. Brown(Children's National), Jorge A. Quiroz(Solidus Biosciences (United States))
Cited by 20
Related Papers
The Central Nervous System-Restricted Transcription Factor Olig2 Opposes p53 Responses to Genotoxic Damage in Neural Progenitors and Malignant Glioma
|Cancer Cell|2011|156
Multi-omic integrated networks connect DNA methylation and miRNA with skeletal muscle plasticity to chronic exercise in Type 2 diabetic obesity
|Physiological Genomics|2014|145
Requirement of the ATM/p53 Tumor Suppressor Pathway for Glucose Homeostasis
|Molecular and Cellular Biology|2010|118
Interlaboratory Study on Differential Analysis of Protein Glycosylation by Mass Spectrometry: The ABRF Glycoprotein Research Multi-Institutional Study 2012
|Molecular & Cellular Proteomics|2013|115
Cerebral organoids derived from Sandhoff disease-induced pluripotent stem cells exhibit impaired neurodifferentiation
|Journal of Lipid Research|2018|109